1. Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res. 2014;6(1):1-7. 2. Thaddeus S, Maine D. Too far to walk: maternal mortality in context. Soc Sci Med. 1994;38(8):1091-1110. 3. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095. 4. Bartsch E, Medcalf KE, Park AL, Ray JG, High Risk of Pre-eclampsia Identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. 5. Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol. 1967;93(2):569-579. 6. Doherty A, McLaughlin K, Kingdom JC. Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond. Clinics in perinatology. 2020;47(3):653-670. 7. Mazzola A, Magro B, Perdigao F, et al. Acute liver failure and HELLP syndrome: A clinical case and literature review. Clin Res Hepatol Gastroenterol. 2021;45(2):101498. 8. Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018;72(1):24-43. 9. Konijnenberg A, Stokkers EW, van der Post JA, et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997;176(2):461-469. 10. Macey MG, Bevan S, Alam S, et al. Platelet activation and endogenous thrombin potential in pre-eclampsia. Thrombosis research. 2010;125(3):e76-81. 11. Mattheij NJ, Gilio K, van Kruchten R, et al. Dual mechanism of integrin alphaIIbbeta3 closure in procoagulant platelets. The Journal of biological chemistry. 2013;288(19):13325-13336.